We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZIMV
10926
PUT
DELISTED
ZimVie
ZIMV
$110K ﹤0.01%
+11,130
New +$180K
VIRX
10927
PUT
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$110K ﹤0.01%
25,700
-4,100
-14% -$17.4K
BBVA icon
10928
CALL
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
$109K ﹤0.01%
24,400
-900
-4% -$4.08K
BGC icon
10929
PUT
BGC Group
BGC
$5.33B
$109K ﹤0.01%
34,600
+6,200
+22% +$24K
CRDF icon
10930
PUT
Cardiff Oncology
CRDF
$74.9M
$109K ﹤0.01%
71,100
+6,500
+10% +$15.6K
CRMD icon
10931
PUT
CorMedix
CRMD
$588M
$109K ﹤0.01%
38,600
-3,000
-7% -$12.5K
QIPT
10932
DELISTED
Quipt Home Medical
QIPT
$109K ﹤0.01%
+26,204
New +$131K
SBEV icon
10933
Splash Beverage Group
SBEV
$2.55M
$109K ﹤0.01%
496
+274
+123% +$104K
UP icon
10934
CALL
Wheels Up
UP
$182M
$109K ﹤0.01%
476
+203
+74% +$81.4K
CPUH
10935
PUT
DELISTED
Compute Health Acquisition Corp.
CPUH
$109K ﹤0.01%
11,000
-57,600
-84% -$567K
ML
10936
CALL
DELISTED
MoneyLion Inc.
ML
$109K ﹤0.01%
4,060
-423
-9% -$19.4K
GSQD.U
10937
DELISTED
G Squared Ascend I Inc. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant to acquire one Class A ordinary share
GSQD.U
$109K ﹤0.01%
10,992
+65
+0.6% +$643
LMAOU
10938
DELISTED
LMF Acquisition Opportunities Inc. Unit
LMAOU
$109K ﹤0.01%
10,563
+100
+1% +$1.03K
PMCB icon
10939
PUT
PharmaCyte Biotech
PMCB
$5.92M
$108K ﹤0.01%
44,900
-17,700
-28% -$44.8K
WSR
10940
PUT
DELISTED
Whitestone REIT
WSR
$108K ﹤0.01%
+12,800
New +$131K
LENZ
10941
CALL
LENZ Therapeutics
LENZ
$149M
$108K ﹤0.01%
+4,857
New +$116K
VBIV
10942
CALL
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$108K ﹤0.01%
5,120
-30
-0.6% -$809
AKLI
10943
CALL
DELISTED
Akili Inc
AKLI
$108K ﹤0.01%
+47,800
New +$343K
CONX
10944
DELISTED
CONX Corp. Class A Common Stock
CONX
$108K ﹤0.01%
10,812
-56,835
-84% -$565K
RVLP
10945
PUT
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$108K ﹤0.01%
+51,400
New +$99.9K
PRTK
10946
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$108K ﹤0.01%
41,883
-57,979
-58% -$144K
AUS.U
10947
DELISTED
Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
AUS.U
$108K ﹤0.01%
10,996
-100
-0.9% -$982
SGC icon
10948
CALL
Superior Group of Companies
SGC
$208M
$107K ﹤0.01%
12,100
-26,000
-68% -$374K
TOKE
10949
DELISTED
Cambria Cannabis ETF
TOKE
$107K ﹤0.01%
16,405
-4,073
-20% -$32.1K
XNET
10950
Xunlei
XNET
$334M
$107K ﹤0.01%
77,038
+46,247
+150% +$73.1K

Similar funds

Ken Griffin's Q3 2022 Portfolio in Review

As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
  • Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.